(3aS,8aR)-2-(Quinolin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 1g

HPLC column NUCLEODUR® 100-3 C18 ec 3 µm, 100 mm, 4 mm, 1 Piece(s)

5-Bromo-4-methoxy-1H-indazole, 95.0%, 100mg

(R)-2-(2-methoxyphenyl)pyrrolidine, 98%, 100mg

6-Bromo-2-fluoro-3-hydroxybenzaldehyde, 97%, 100mg

8-Methylpyrido[2,3-b]pyrazine, 95.0%, 1g

2-Chloro-N-(4-methoxybenzyl)aniline, 98%, 5g

Methyl 2-((tert-butyldimethylsilyl)oxy)acetate, 97%, 10g

n-(3-Aminopropyl)benzamide, 97%, 500mg

2,6-Difluoro-3-iodopyridine, 95.0%, 25g

4-Oxo-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-5-carbaldehyde, 90.0%, 250mg

[(1-isopropyl-1,2,3,4-tetrahydro-6-quinolinyl)methyl]methylamine diethanedioate, 95.0%, 1g

4-NITRONAPHTHALEN-2-OL, 95%, 250mg